ATE251103T1 - Synthetische endogene cannabinoidanaloge und ihre verwendungen - Google Patents

Synthetische endogene cannabinoidanaloge und ihre verwendungen

Info

Publication number
ATE251103T1
ATE251103T1 AT99913555T AT99913555T ATE251103T1 AT E251103 T1 ATE251103 T1 AT E251103T1 AT 99913555 T AT99913555 T AT 99913555T AT 99913555 T AT99913555 T AT 99913555T AT E251103 T1 ATE251103 T1 AT E251103T1
Authority
AT
Austria
Prior art keywords
compositions
endogene
synthetic
compound
cannabinoid analogues
Prior art date
Application number
AT99913555T
Other languages
English (en)
Inventor
Raphael Mechoulam
Esther Fride
Shabat Shimon Ben
Tzviel Sheskin
Aviva Breuer
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE251103T1 publication Critical patent/ATE251103T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/15—Unsaturated ethers containing only non-aromatic carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
AT99913555T 1998-04-03 1999-03-30 Synthetische endogene cannabinoidanaloge und ihre verwendungen ATE251103T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8067998P 1998-04-03 1998-04-03
PCT/IL1999/000187 WO1999051560A1 (en) 1998-04-03 1999-03-30 Synthetic endogenous cannabinoids analogues and uses thereof

Publications (1)

Publication Number Publication Date
ATE251103T1 true ATE251103T1 (de) 2003-10-15

Family

ID=22158929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913555T ATE251103T1 (de) 1998-04-03 1999-03-30 Synthetische endogene cannabinoidanaloge und ihre verwendungen

Country Status (9)

Country Link
US (1) US6531636B1 (de)
EP (1) EP1066235B1 (de)
AT (1) ATE251103T1 (de)
AU (1) AU765670B2 (de)
CA (1) CA2326766A1 (de)
DE (1) DE69911755T2 (de)
ES (1) ES2209417T3 (de)
IL (1) IL138690A0 (de)
WO (1) WO1999051560A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1189603A2 (de) 1999-03-22 2002-03-27 Immugen Pharmaceuticals, Inc. Behandlung von immunerkrankungen wie hiv-erkrankung und neoplastischen erkrankungen
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
DE60106026T2 (de) * 2000-06-23 2006-02-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem 2-arachidonylglycerol (2-ag)-ein hemmer des tumor nekrose faktors-alfa und neuroprotektor des gehirns bei geschlossenen kopfverletzungen
WO2003075917A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
JP2006517194A (ja) 2002-06-06 2006-07-20 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム 骨成長を調節するための方法、組成物および製造物
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
EP1660071A1 (de) 2003-08-18 2006-05-31 Btg International Limited Behandlung von neurodegenerativen erkrankungen
IL160420A0 (en) * 2004-02-16 2004-07-25 Yissum Res Dev Co Treating or preventing diabetes with cannabidiol
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US7781650B2 (en) * 2007-04-30 2010-08-24 Monsanto Technology Llc Plants and seeds of corn variety CV202909
US7989555B2 (en) 2007-05-21 2011-08-02 Global Agritech, Inc. Glycerol derivatives and methods of making same
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
WO2017222713A1 (en) * 2016-06-24 2017-12-28 Indiana University Research & Technology Corporation A gpr119-based signaling system in the murine eye regulates intraocular pressure in a sex-dependent manner

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103932A (en) * 1992-11-30 1997-02-18 Yissum Res & Dev Fatty acid and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US6531636B1 (en) 2003-03-11
IL138690A0 (en) 2001-10-31
ES2209417T3 (es) 2004-06-16
WO1999051560A1 (en) 1999-10-14
CA2326766A1 (en) 1999-10-14
EP1066235A1 (de) 2001-01-10
DE69911755T2 (de) 2004-08-12
AU765670B2 (en) 2003-09-25
AU3165399A (en) 1999-10-25
EP1066235B1 (de) 2003-10-01
DE69911755D1 (de) 2003-11-06

Similar Documents

Publication Publication Date Title
ATE251103T1 (de) Synthetische endogene cannabinoidanaloge und ihre verwendungen
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
BR0208489A (pt) Derivados de n-(arilsulfonil) beta-aminoácidos, comportando um grupo aminoetilado substituìdo, o respectivo processo de preparação e as composições farmacêuticas que os contêm
ATE361288T1 (de) N-(3,-dimethylindolin-6-yl)ä2-ä(4-
TNSN02022A1 (fr) Triazolopyridines anti-inflammatoires nouvelles, et compositions les contenant
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
SE0302760D0 (sv) New compounds
BR0009167A (pt) Inibidores de enzima impdh
DE60227492D1 (de) Hemmstoffe der akt aktivität
MXPA04004301A (es) Bencimidazoles sustituidos utiles como inhibidores de la proteina cinasa.
CY1107899T1 (el) 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειϊκο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας
HUP0102550A2 (hu) IgE választ befolyásoló tulajdonságú vegyületek
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
ATE448194T1 (de) Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
TR200101120T2 (tr) Serin proteaz inhibitörü
EA200301204A1 (ru) Фармацевтически активные производные нуклеозида, способ их получения, их применение (варианты) и содержащая их фармацевтическая композиция, способ профилактики и/или лечения заболеваний и нарушений млекопитающих (варианты), комбинация лекарственных средств и ее применение (варианты)
BR0108816A (pt) Derivados de quinolina como antagonistas alfa-2
BR9809022A (pt) Composições antiinflamatórias nasais tópicas
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
BR0113389A (pt) Compostos que inibem a atividade do fator xa
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties